EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Colorectal Cancer Pulmonary Metastasectomy: When, Why and How

Francesco Petrella iD, Federica Danuzzo iD, Maria Chiara Sibilia, Sara Vaquer, Raffaella Longarini, Alessandro Guidi, Federico Raveglia, Lidia Libretti, Emanuele Pirondini, Andrea Cara, Enrico Mario Cassina, Antonio Tuoro und 1 weitere

Cancers · 03.04.2024 · 16 (7) · 1408

DOI: 10.3390/cancers16071408 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 03.04.2024. Verfasst von Francesco Petrella und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori, Via GB Pergolesi 33, 20900 Monza, Italy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer is the third-most-diagnosed cancer in males and in females, representing 8% of estimated new cases, and the third cause of cancer-related death in both sexes, accounting for 9% of cancer deaths in men and 8% in women. About 20% of patients diagnosed with CRC present metastatic disease. Although lung metachronous or synchronous metastatic spread without other involved sites has been reported in only a small proportion of patients, considering that this tumor is frequently diagnosed, the clinical approach to CRC pulmonary metastases represents a major issue for thoracic surgeons and CRC oncologists. Among patients diagnosed with pulmonary metastases from CRC, about 9–12% are eligible for local treatments with radical intent, including surgical resection, SBRT (stereotactic body radiation therapy) and ablation therapy. Due to the lack of randomized controlled trials among different local strategies, there is no definitive evidence about the optimal approach, although surgical resection is considered the most effective therapeutic option in this clinical scenario. Oncological achievement of primary radical resection, the biology of primary tumor and metastatic sites, disease free interval and or progression free survival are independent prognostic factors which make it possible to define a cohort of patients which might significantly benefit from pulmonary metastasectomy.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancerdisease free intervaloverall survivalpulmonary metastasectomy

Autor:innen und Institutionen

  • Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori, Via GB Pergolesi 33, 20900 Monza, Italy.
  • Division of Medical Oncology, Fondazione IRCCS San Gerardo dei Tintori, Via GB Pergolesi 33, 20900 Monza, Italy.
  • School of Medicine and Surgery, University of Milano Bicocca, 20126 Milan, Italy.

ORCID-Profile: Francesco Petrella, Federica Danuzzo, Diego Cortinovis

Zitieren

APA

Petrella, F., Danuzzo, F., Sibilia, M. C., Vaquer, S., Longarini, R., Guidi, A., Raveglia, F., Libretti, L., Pirondini, E., Cara, A., Cassina, E. M., Tuoro, A., & Cortinovis, D. (2024). Colorectal Cancer Pulmonary Metastasectomy: When, Why and How. Cancers, 16(7), 1408. https://doi.org/10.3390/cancers16071408

Vancouver

Petrella F, Danuzzo F, Sibilia MC, Vaquer S, Longarini R, Guidi A, et al. Colorectal Cancer Pulmonary Metastasectomy: When, Why and How. Cancers. 2024;16(7):1408. doi:10.3390/cancers16071408

BibTeX
@article{Petrella2024,
  author = {Petrella, Francesco and Danuzzo, Federica and Sibilia, Maria Chiara and Vaquer, Sara and Longarini, Raffaella and Guidi, Alessandro and Raveglia, Federico and Libretti, Lidia and Pirondini, Emanuele and Cara, Andrea and Cassina, Enrico Mario and Tuoro, Antonio and Cortinovis, Diego},
  title = {Colorectal Cancer Pulmonary Metastasectomy: When, Why and How},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {7},
  pages = {1408},
  doi = {10.3390/cancers16071408}
}
Kostenlos starten →